Pseudoephedrine joins PPA as first-line drug therapy for incontinence -- AHCPR guidelines.
This article was originally published in The Tan Sheet
Executive Summary
PSEUDOEPHEDRINE RECOMMENDED AS FIRST-LINE DRUG FOR STRESS INCONTINENCE in an updated version of urinary incontinence clinical practice guidelines released March 5 by the Agency for Health Care Policy and Research. The AHCPR guidelines list 15-30 mg of pseudoephedrine three times daily as "first-line pharmacologic therapy for women with [stress incontinence] who have no contraindications for its use, particularly hypertension."